Guangxi Bangqi Pharmaceutical Group

Guangxi Bangqi Pharmaceutical Group is a Chinese privately held pharmaceutical manufacturer focused primarily on traditional Chinese medicine and related healthcare products. Founded in 1996 and headquartered in Qinzhou, Guangxi, the company operates as an integrated group spanning research, manufacturing, sales, and service, with more than 10 subsidiaries and four production bases. Bangqi markets a broad portfolio of approved products across 19 dosage forms, with hundreds of drug approvals, numerous exclusive products, and several products holding new-drug certificates. Its marketed portfolio includes products such as Guilong Ointment, compound houttuynia granules, Jinji capsules, Wushen Anshen oral liquid, Luohanguo cough syrup, anti-cervicitis granules, and Sanshen Yiqi oral liquid. The company emphasizes ethnic medicine, secondary development of established products, and modernization of Chinese-medicine manufacturing, supported by GMP-compliant facilities and in-house quality-control capabilities.